Russian scientists have developed a new treatment for the most common form of rheumatism - osteoporosis. The Bioform scientific center press service said that on 30 October 2003 a commission on traumatology and orthopedics for the Health Ministry approved the application of a new device for treating osteoporosis, which was developed by employees of the center. The device will be sold on the Russian market later in 2003 and in Europe in the second-half of 2004.
Commission Chairman Gennady Onoprienko said that 'the emergence of the effective and accessible treatment of this, in essence, incurable disease will play a great role in changing the difficult situation in regard to therapy and treatment of osteoporosis in Russia and around the world.'
The Bioform press service said the in the US alone 43 million people (15% of the population) suffers from arthritis and osteoarthritis. Specialists say that the number will increase to 60 million (18.2% of the population) by 2020. More than half of the patients are less than 65. The US Health Department estimates that arthritis treatment costs the US economy approximately USD 65 billion per year.